Elisa Piovano - Concepedia

Author

Elisa Piovano

University of Turin ORCID

Also Known As

A Daniele, E Piovano, E. Piovano, Elisa Piovano, Federica Perelli, Francesco Pata, Luca Pellegrino, Piovano Elisa

Publications

Citations

H-Index

Concepts

All Affiliations

University of Turin A. O. Ordine Mauriziano di Torino Azienda Ospedaliera Citta' della Salute e della Scienza di Torino Piedmont Reference Center for Epidemiology and Cancer Prevention European Institute of Oncology

About

Elisa Piovano is an author at University of Turin specializing in medicine, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	496
2	Obstetrics	7	7	384
3	Public Health	3	3	138
4	Health Sciences	1	1	38
5	Nursing	1	1	10

Elisa Piovano

Publications

748

Citations

H-Index

Page 1

	Year	Citations
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case–control study on survival in patients with two year follow-up Anna Fagotti, Barbara Costantini, Marco Petrillo, Gynecologic Oncology Cytoreductive SurgerySurgical OncologyCase–control StudyMedicineCancer Management	2012	106
Atezolizumab and chemotherapy for advanced or recurrent endometrial cancer (AtTEnd): a randomised, double-blind, placebo-controlled, phase 3 trial Nicoletta Colombo, Elena Biagioli, Kenichi Harano, The Lancet Oncology Gynecological SurgeryMedicineMetronomic TherapyGynecologyRecurrent Endometrial Cancer	2024	89
Is there a role for postoperative treatment in patients with stage Ib2–IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study Fabio Landoni, Enrico Sartori, T Maggino, Gynecologic Oncology Surgical OncologyCervical CancerRadical SurgeryMedicineCancer Management	2013	74
Could follow-up different modalities play a role in asymptomatic cervical cancer relapses diagnosis? Paolo Zola, Luca Fuso, S. Mazzola, Gynecologic Oncology Cervical Cancer ManagementCervical Cancer ScreeningCervical CancerDifferent ModalitiesCancer Recurrence	2007	66
Pathological response on surgical samples is an independent prognostic variable for patients with Stage Ib2–IIb cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: An Italian multicenter retrospective study (CTF Study) Angiolo Gadducci, Enrico Sartori, T Maggino, Gynecologic Oncology Surgical OncologyCervical Cancer ManagementCervical CancerGynecological SurgeryMedicine	2013	62
Diagnostic accuracy and cost‐effectiveness of different strategies to triage women with adnexal masses: a prospective study Elisa Piovano, Camilla Cavallero, Luca Fuso, Ultrasound in Obstetrics and Gynecology	2016	43
LBA40 Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma Nicoletta Colombo, Kenichi Harano, Emma Hudson, Annals of Oncology MedicineGynecologyLba40 Phase IiiCancer TreatmentAdvanced/recurrent Endometrial Carcinoma	2023	41
The ADNEX model to triage adnexal masses: An external validation study and comparison with the IOTA two-step strategy and subjective assessment by an experienced ultrasound operator E. Viora, Elisa Piovano, Cinzia Baima Poma, European Journal of Obstetrics & Gynecology and Reproductive Biology Medical UltrasoundAdnex ModelMedical ImagingExperienced Ultrasound OperatorDiagnosis	2020	38
Effectiveness of Intensive Versus Minimalist Follow-Up Regimen on Survival in Patients With Endometrial Cancer (TOTEM Study): A Randomized, Pragmatic, Parallel Group, Multicenter Trial Paolo Zola, Giovannino Ciccone, Elisa Piovano, Journal of Clinical Oncology	2022	37
Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma Jvan Casarin, Giorgio Bogani, Elisa Piovano, Journal of Gynecologic Oncology	2020	32

Page 1